The dept is the state-level clinical pharmaceutical research base of Chinese medicine, and master degree and doctoral degree education center of TCM internal medicine, Combination of Chinese medicine with Western medicine. It is also the post-doctoral mobile education station of TCM internal medicine.
The department sees over 50000 patients annually. It has achieved leading level in treating oncology patient by combination of Chinese medicine with Western medicine. In the recent 20 years, they have developed many new TCM medicine in treating lung cancer, liver cancer, oncology pain, leucopenia, thrombocytopenia. The newly found medicine -Kang Laite injection, which is one of the Type-II anti-cancer medicines, is on international advanced level. It has been awarded with State Invention Prize, First Prize of State Administration Bureau of Chinese Medicine, and Second prize of State Science & Technology Advancement.